Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry

The effectiveness and safety of venous thromboembolism (VTE) treatment with apixaban, demonstrated in phase III trials, need to be confirmed in daily care. Using data from the prospective, noninterventional cross-indication Dresden NOAC Registry we evaluated rates of VTE recurrence and bleeding comp...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:TH Open
Päätekijät: Beyer-Westendorf, Jan, Marten, Sandra, Tittl, Luise, Naue, Christiane, Bornhäuser, Martin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Georg Thieme Verlag KG 2021
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8096533/
https://ncbi.nlm.nih.gov/pubmed/33969261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0041-1728675
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia